MedLumics (Spain) a development-stage diagnostic device company focused on optical coherence tomography imaging for ophthalmology and intravascular imaging in cardiology, dermatology and dentistry, closed a $3.25M Series A financing. Participants include Ysios Capital Partners and Caixa Capital.

Cervilenz (Chagrin Falls, OH) a development-stage device company focused on the a disposable to identify and manage pregnant women at high risk for preterm birth, closed an $8.35M Series A financing. Participants include Arboretum Ventures and Chrysalis Ventures.

Leonardo Biosystems (Houston, TX) a development-stage biopharmaceutical company focused on drug delivery technology, closed a $1.25M Series A financing, bringing the total round to $2.5M. Participants include Texas Emerging Technology Fund.

Tangent Medical Technologies (Ann Arbor, MI) a development-stage medical device company focused on peripheral intravenous delivery systems, closed a $4.5M Series A financing. Participants include Arboretum Ventures, Flagship Ventures and Osage Ventures.

Atox Bio (Israel) a clinical-stage biotechnology company focused on small molecules for the treatment of severe bacterial infections, sepsis, necrotizing soft tissue infections and intra-abdominal infections, closed a $3.25M Series A financing. Participants include Esperante.

Provenance Biopharmaceuticals (Waltham, MA) a clinical-stage biopharmaceutical company focused on monoclonal antibody therapy for non-Hodgkins lymphoma and other hematological cancers, closed a $8M Series A financing. Participants include Alopexx Enterprises.

PharmacoFore (San Carlos, CA) a clinical-stage biopharmaceutical company focused on improvement of existing drugs preventing misuse, abuse, and overdose of prescription medications for pain, closed a $10M Series A financing. Participants include Founders Fund.

Innopharma (Piscataway, NJ) a development-stage specialty pharmaceutical company focused on generics and drug delivery technology platforms for existing drugs, closed a $15M Series A financing. Participants include Thomas, McNerney & Partners.

Karyopharm Therapeutics (Natick, MA) a preclinical-stage small molecule company focusing on the treatment of cancer and inflammation, closed a $10M Series A financing, bringing the total round to $30M. Participants include Chione.

NanoDetection Technology (Cincinnati, OH) a development-stage in vitro poc diagnostic platform focused on uses in healthcare, food safety and bioterrorism, closed a $2.3M Series A financing. Participants include CincyTech.
Thanx for your patience as we catch-up.

Acutus Medical (San Diego, CA) a development-stage medical device company focused on electrophysiological mapping technology for the treatment of cardiac arrhythmias, closed a $1M Series A financing. Participants include Index Ventures.
Thanx for your patience as we catch-up.

Second Genome (San Francisco, CA) a commercial-stage microbial profiling company designed to enable diagnostic/prognostic signatures and target identification, closed a $5M Series A financing. Participants include Advanced Technology Ventures, Morgenthaler Ventures, Wavepoint Ventures and Seraph Group.
Thanx for your patience as we catch-up.

SironRx Therapeutics (Cleveland, OH) a clinical-stage regenerative therapy company focused on wound repair and scarring prevention, closed a $3.4M Series A financing. Participants include North Coast Angel Fund, Cleveland Clinic, JumpStart, Fletcher Spaght Investments, Glengary, Ohio Tech Angel Fund and Early Stage Partners.
Thanx for your patience as we catch-up.